Latest Conference Articles

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.

AAO recap: Scientific findings and interviews from New Orleans

AAO recap: Scientific findings and interviews from New Orleans

November 23rd 2021

AAO

A brief overview of the plethora of findings presented at the 2021 American Academy of Ophthalmology meeting held November 12-15 in New Orleans, LA.

Study: PDS offers efficient drug delivery to retina for wet AMD

Study: PDS offers efficient drug delivery to retina for wet AMD

November 16th 2021

AAO

Mark Wieland, MD, explores how Port Delivery System with ranibizumab provides drug delivery over an extended period.

Faricimab provides sustained retinal stability in DME

Faricimab provides sustained retinal stability in DME

November 15th 2021

AAO

Veeral Sheth, MD, presents research finding faricimab, a bispecific monoclonal antibody, provided sustained retinal stability in patients with diabetic macular edema (DME) compared with other retinal treatments.

AMD progression associated with plasma metabolomic profiles

AMD progression associated with plasma metabolomic profiles

November 15th 2021

AAO

Ines Lains, MD, PhD, explores how mechanisms of AMD progression currently remain poorly understood and the tools to predict and halt progression are limited.

Influence of universal face masks on endophthalmitis risk post-anti-VEGF injections

Influence of universal face masks on endophthalmitis risk post-anti-VEGF injections

November 14th 2021

AAO

Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.

FDA-approved eye drops target presbyopia patients

FDA-approved eye drops target presbyopia patients

November 14th 2021

AAO

Cathleen McCabe, MD, discusses VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, and how it provides opportunities for patients looking for spectacle independence.

ImprimisRx offers a look at three new products in the pipeline

ImprimisRx offers a look at three new products in the pipeline

November 14th 2021

AAO

ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021.

Rare ocular surface tumors often prove deadly

Rare ocular surface tumors often prove deadly

November 14th 2021

AAO

Nathan Hall, BS, MS, presents research on how epidemiologic analysis of malignant ocular surface tumors found significant differences in geographic prevalence rates in the United States.

Study examines dosing variability with aflibercept pre-filled syringes

Study examines dosing variability with aflibercept pre-filled syringes

November 14th 2021

AAO

Roger A. Goldberg, MD, MBA, notes how small misalignments in the plunger can lead to possible overdosing.

DME: Changes to CST linked to worse visual outcomes

DME: Changes to CST linked to worse visual outcomes

November 13th 2021

AAO

Ajay Kuriyan, MD, discusses fluctuations in central subfield thickness associated with worse visual outcomes in patients with diabetic macular edema in clinical trial setting.